In support of Ray's opinion on amino acids like glutamine and arginine fueling cancer growth, this study found that melanoma cancer needs glutamine for its growth and without a steady supply of glutamine the cancer dies.
So, glutamine and arginine restriction / depletion seem to be viable approaches to cancer control / cure and as far as I know there is a clinical trial in Germany for colon cancer using the chemical L-NAME (arginine depletor). If someone knows of clinical trial or human study using glutamine restriction / depletion please share it on the forum.
http://beaker.sanfordburnham.org/2015/0 ... er-growth/
"...Researchers at Sanford-Burnham have discovered that without a source of glutamine—one of the 20 amino acids used to build proteins—melanoma cells will stop proliferating and die. Their craving for glutamine stems from their ability to “abuse” this essential nutrient by using it as an additional source of carbon and energy. The findings present a rational basis for a treatment strategy that limits the supply of glutamine to tumors, potentially through nutritional interventions or inhibitors of glutamine uptake. The results of the study appear online in Oncotarget today."
So, glutamine and arginine restriction / depletion seem to be viable approaches to cancer control / cure and as far as I know there is a clinical trial in Germany for colon cancer using the chemical L-NAME (arginine depletor). If someone knows of clinical trial or human study using glutamine restriction / depletion please share it on the forum.
http://beaker.sanfordburnham.org/2015/0 ... er-growth/
"...Researchers at Sanford-Burnham have discovered that without a source of glutamine—one of the 20 amino acids used to build proteins—melanoma cells will stop proliferating and die. Their craving for glutamine stems from their ability to “abuse” this essential nutrient by using it as an additional source of carbon and energy. The findings present a rational basis for a treatment strategy that limits the supply of glutamine to tumors, potentially through nutritional interventions or inhibitors of glutamine uptake. The results of the study appear online in Oncotarget today."